RVL Pharmaceuticals
Ada Tinescu is an experienced finance professional with a strong background in financial analysis and cost accounting. Currently serving as a Senior Finance Systems Analyst at RVL Pharmaceuticals since June 2018, Ada has previously held significant positions at Fast Retailing as both a Business Analyst and Senior Cost Accountant, as well as at Polo Ralph Lauren as a Senior Cost Accountant. Early career experiences include roles as a Consultant Senior Accountant at Loral Skynet, Cost Accountant at Horizon Group USA, and Accountant/Business Analyst at Montero. Ada holds a Bachelor's degree in Mathematics from the University of Bucharest, obtained between 1992 and 1997.
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.